Biotechnology

Thursday Feb 18, 2021 - 11:58 am

InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces $17.6M Private Placement

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced its entry into securities purchase agreements with certain institutional and accredited investors to raise approximately $17.6 million through the issuance of an aggregate of 9,043,766 shares of its common stock and warrants to purchase up to an aggregate of 4,521,883 shares of common stock,…

Wednesday Feb 17, 2021 - 12:17 pm

InvestorNewsBreaks – Brain Scientific Inc. (BRSF) Signs Memorandum of Understanding with Ehave, Inc. (EHVVF) to Map Brain Response

Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company with two FDA-cleared products, has entered into a memorandum of understanding (“MoU”) with Ehave, Inc. (OTC: EHVVF), a provider of digital therapeutics for the psychedelic and mental health sectors. The agreement calls for the two companies to work together to map brain response to psychedelics being administered as a treatment for chronic pain, depressions (both major and persistent),…

Wednesday Feb 17, 2021 - 10:50 am

InvestorNewsBreaks – Predictive Oncology (NASDAQ: POAI) Closes on $7.4M Registered Direct Offering, Announces Breakthrough Discoveries

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that it had closed on its previously announced registered direct offering. The offering, comprised of 4,222,288 shares of POAI common stock sold at $1.75 per share, totaled $7.4 million in gross proceeds for the company, before expenses were deducted. The shares were priced at-the-market under…

Tuesday Feb 16, 2021 - 2:02 pm

InvestorNewsBreaks – Artelo Biosciences Inc. (NASDAQ: ARTL) Appoints Senior Pharmaceutical Exec as New SVP, Chief Scientific Officer

Artelo Biosciences (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogenous signaling pathways including the endocannabinoid system, today announced the appointment of Andrew Yates, Ph.D, as senior vice president and chief scientific officer. Dr. Yates is an experienced senior pharmaceutical executive, having most recently served at AstraZeneca in significant roles across a number of functional areas including development…

Tuesday Feb 16, 2021 - 11:06 am

InvestorNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces Completion of European CE-IVD Application for 25-Minute COVID-19 RT-PCR Test

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) has made a significant announcement, along with its exclusive German diagnostics development partner, 3a-diagnostics GmbH ("3a"). The companies have completed all actions and procedures required for the European regulatory application for the rapid point-of-care SARS-CoV-2 (COVID-19) RT-PCR Test System. The announcement noted that ISO 13485 approval for 3a as a medical device manufacturer is expected in the next…

Friday Feb 12, 2021 - 11:59 am

InvestorNewsBreaks — MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Qualifies to Trade on OTCQX Best Market

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops, has announced it has qualified to trade on the OTCQX(R) Best Market; the company’s symbol was also upgraded to OTCQX from the OTCQB(R) Venture Market. Effective Friday, Feb. 12, 2021, the company will begin trading using its MGROF symbol. The OTCQX Market…

Friday Feb 12, 2021 - 11:46 am

InvestorNewsBreaks – LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) Announces Change in Management, New Board Appointment

LexaGene Holdings (TSXV: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced that Daryl Rebeck will resign from the board and his position as the president of LexaGene effective Feb. 15, 2021. Stephen J. Mastrocola has joined the company’s board of directors and brings almost 40 years of accounting and auditing experience working with public and private…

Friday Feb 12, 2021 - 10:55 am

InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Releases Q3 Financial Report, Clinical Studies Update

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new-generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, has reported its financial numbers for its fiscal 2021 third quarter, ending Dec. 21, 2020. Highlights of the report are the company’s strengthened balance sheet following the closing of its recent underwritten public offering,…

Thursday Feb 11, 2021 - 2:53 pm

InvestorNewsBreaks – RYAH Group Inc. Enters Strategic Partnership to Establish Market Standard for Vaporizing

RYAH Group, a leading digital health care analytics and technology company, recently entered into a research-and-distribution arrangement with THC Lab. Appearing to be an ideal partner for RYAH as the company expands globally, THC Lab specializes in providing products and services to compounding pharmacies in Italy and other European countries in the specific field of medical cannabis. The agreement outlines the parameters for the launch…

Thursday Feb 11, 2021 - 2:34 pm

InvestorNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Provides Update on Biopesticide Pipeline

MustGrow (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) is an innovative agriculture biotech company focused on providing natural biological protection for high value crops and other markets. Recently the company provided an update of its biopesticide product pipeline. The company — by extracting natural compounds from within the mustard seed — the mustard plant’s natural defense mechanism — has provided natural solutions to potentially replace widely…

Thursday Feb 11, 2021 - 10:16 am

InvestorNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces Ability to Speed Up COVID-19 Testing Using PCR Equipment

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, has partnered with a German diagnostics firm to become a leader in commercializing breakthrough tech in rapid, definitive testing for COVID-19 in strategic and convenient point-of-care (“POC”) settings. A recent article noted that, using standard polymerase chain reaction (“PCR”) equipment, XPhyto has the ability to significantly speed…

Thursday Feb 11, 2021 - 10:13 am

InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces $7.4M Registered Direct Offering

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced its entry into definitive agreements with several institutional and accredited investors for the issuance and sale of an aggregate of approximately 4,222,288 shares of its common stock. The company expects gross proceeds of approximately $7.4 million, with each of the shares sold a purchase…

Wednesday Feb 10, 2021 - 3:15 pm

InvestorNewsBreaks – United Medical Equipment Business Solutions Network Inc. Provides Antigen Rapid POC Test as part of Comprehensive COVID-19 Strategy

United Medical Equipment (“UME,” “UMEBSNI”) is committed to offering high-quality COVID-19 services, solutions and supplies. Among these, UME provides the CareStart(TM) COVID-19 Antigen Rapid POC test. The test can be administered by authorized laboratories and at the point of care by medical professionals to detect the presence of the SARS-CoV-2 nucleocapsid protein antigen. The innovative test features a 10-minute processing time and provides the capability…

Wednesday Feb 10, 2021 - 3:04 pm

InvestorNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Anticipates ‘Breakout Year’ in 2021

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, expects to achieve important milestones in the year ahead. The company’s proprietary i/Blue Imaging System is designed to significantly enhance surgeons’ ability to visualize and remove cancer cells using blue light by combining advanced optics and light sensors with a contrast imaging agent. The system’s key feature is its adaptability to almost any scope already…

Wednesday Feb 10, 2021 - 12:38 pm

InvestorNewsBreaks – LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) Configures MiQLab(TM) to Detect Variants of COVID-19 Pathogen

LexaGene Holdings (TSXV: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced that it has successfully configured a MiQLab(TM) system to detect mutant sequences unique to the United Kingdom (“UK, B.1.1.7”) 1 and South African (“SA, B.1.351”) 2 variants of SARS-CoV-2, the pathogen that causes COVID-19. “Just three weeks ago, we designed assays to detect the UK…

Tuesday Feb 09, 2021 - 12:04 pm

InvestorNewsBreaks — MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Releases Further Lab Results Validating Natural Biopesticide Control of Banana Disease

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops, as released additional lab results confirming its mustard-derived natural biopesticide ability to obtain 100% control of on the disease Fusarium wilt TR4. A banana disease often referred to as the Panama disease, Fusarium wilt TR4 is destroying the $25 billion global banana industry.…

Tuesday Feb 09, 2021 - 10:25 am

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Forms Clinical Advisory Board, Announces $25M Registered Direct Offering

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, has announced that it has created a Clinical Advisory Board (“CAB”). The company has named world-renowned medical and clinical experts as the board’s first members. The purpose of the board is to provide expert guidance for Genprex’s novel gene therapy clinical development programs in cancer and diabetes.…

Monday Feb 08, 2021 - 1:08 pm

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Acquire Assets of International Agrochemical Developer and Supplier

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide biotechnology, biotherapeutics and other industries, today announced its entry into a letter of intent to purchase the assets of an internationally based developer and supplier of organically natural, eco-friendly agrochemicals. The company offers sought-after alternatives to synthetic pesticides and fertilizers…

Monday Feb 08, 2021 - 11:48 am

InvestorNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) to Collaborate with LA Retail Hot Spot

PlantX (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF), a multifaceted marketplace providing consumers all things plant based, has announced a collaboration with Farm Cup Coffee. The collaboration should increase PlantX’s presence in one of LA’s most sought-after retail locations. The announcement noted that PlantX will display and sell its houseplants at Farm Cup Coffee’s new location in West Hollywood, California. The company’s plants include a wide range…

Friday Feb 05, 2021 - 3:26 pm

InvestorNewsBreaks – United Medical Equipment Business Solutions Network Inc. Delivers Essential Solutions During Ongoing Pandemic

United Medical Equipment (“UME,” “UMEBSNI”) continues to move quickly to address the unique testing needs created by the ongoing global pandemic. UMEBSNI is a trusted supplier of FDA-approved COVID-19 rapid antigen test kits as part of its efforts to provide essential services during the epidemic. The company’s COVID-19 IgG/IgM Rapid Test Cassette detects coronavirus antibodies that appear in the bloodstream of individuals infected with the…

Thursday Feb 04, 2021 - 3:01 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) on the Verge of Changing History with Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, has set sights on an encouraging future for glioblastoma patients with its upcoming Phase 2 trial of Berubicin. The article detailing this groundbreaking news quoted the company’s CEO John Climaco as saying, “Anthracyclines as a class of chemotherapy have…

Thursday Feb 04, 2021 - 1:13 pm

InvestorNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Harnesses Blue Light, Innovative Technology for Cancer Imaging

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, is harnessing the virtues of blue light in a health-enhancing way. By utilizing the company’s proprietary i/Blue Imaging (TM) System with a contrast agent, surgeons will be able to better visualize the parameters of cancers and develop the appropriate response strategy. Imagin is developing its platform for use in bladder cancer surgery. It relies on…

Thursday Feb 04, 2021 - 11:17 am

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Joins Millions to Recognize World Cancer Day

Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it joins with millions of healthcare advocates around the world in support of World Cancer Day. The designation seeks to raise awareness, elevate public understanding of the global cancer burden, promote greater equity and ensure that cancer control continues to be a priority in the world health and…

Tuesday Feb 02, 2021 - 1:46 pm

InvestorNewsBreaks – Predictive Oncology (NASDAQ: POAI) Ranked as Buy in Litchfield Hills Recent Analyst Report

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has been rated as a “Buy” in the first analyst coverage report released by equity research firm Litchfield Hills Research LLC. POAI was listed as a “Buy” under the report’s three-tiered (buy, hold, sell) rating system. Litchfield Hills Research strictly follows FINRA standards for quality and…

Tuesday Feb 02, 2021 - 10:50 am

InvestorNewsBreaks — MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Announces Trio of Upcoming Investment, Industry Events

MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops, is involved in several upcoming investment and industry conferences, and has released information regarding three upcoming investment and industry conferences in which it will be participating. The events include CSE Tech Tuesdays, a virtual public company showcase, which is today at 4:15 p.m.…

Tuesday Feb 02, 2021 - 10:37 am

InvestorNewsBreaks – Brain Scientific Inc. (BRSF) Marketing VP Authors Article on Increasing Need for Disposable Technologies

Brain Scientific (OTCQB: BRSF) vice president of marketing Stuart Bernstein has authored a DotMed Healthcare Business News article titled “COVID’s influence on neurology drives need for disposable technologies.” In the article, Bernstein notes both time management and infection control as key factors in the growing need for disposable technologies. The article states that headsets with pre-gelled and fixed electrodes could reduce the time-consuming electrode placement process.…

Tuesday Feb 02, 2021 - 10:27 am

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) to Postpone February Virtual Road Show

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform, has announced that it will postpone its upcoming virtual road show. Trxade had previously announced that the road show event would be held Wednesday, Feb. 3, 2021, at 11 a.m. ET. The company, which operates across the United States in all 50 states, will reschedule the event and announce the new date and time. Trxade…

Monday Feb 01, 2021 - 3:23 pm

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Issues Shareholder Letter, Corporate Update

Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, has issued a shareholder letter and corporate update outlining its developments and initiatives for 2020 and anticipated milestones for 2021 and beyond. “We achieved many significant milestones in 2020 that have set the stage for a transformational 2021,” stated Rodney Varner, president and CEO of Genprex. “The primary focus this past…

Monday Feb 01, 2021 - 12:30 pm

InvestorNewsBreaks – Brain Scientific Inc. (BRSF) Featured in Med-Tech Innovation Article

Brain Scientific (OTCQB: BRSF), a neurology focused device and software company, was featured in a recent Med-Tech Innovation article titled, “The need for neurological disposable tech amid the COVID-19 pandemic.” In the piece, Brain Scientific’s VP of Marketing, Stuart Bernstein, examines the need of neurological disposable technology following the effects of COVID0-19. “The solution is clear and has come in the form of disposable EEG…

Friday Jan 29, 2021 - 3:09 pm

InvestorNewsBreaks – United Medical Equipment Business Solutions Network Inc. Poised Across Continuum of Health Care

United Medical Equipment (“UME,” “UMEBSNI”) continues to address unique testing needs created by the ongoing global pandemic. As part of the company’s efforts to provide essential services during the epidemic, UMEBSNI is a trusted supplier of FDA-approved COVID-19 rapid antigen test kits that detect coronavirus antibodies that appear in the bloodstream of infected individuals within 10 minutes. The test can also indicate whether a person…

Friday Jan 29, 2021 - 2:40 pm

InvestorNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Announces Promising Results from CyberAgrot Study

MustGrow (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an innovative agriculture biotech company focused on providing natural biological protection for high value crops, recently released potentially industry-changing results for its initial Colombia laboratory test. The study evaluated the effect of its proprietary mustard-derived organic biopesticide formulation on the disease Fusarium wilt TR4. MustGrow’s study, conducted and reported via third-party laboratory CyberAgrot SAS in Colombia using Instituto…

Thursday Jan 28, 2021 - 2:04 pm

InvestorNewsBreaks – Clearside Biomedical Inc. (NASDAQ: CLSD) Closes Sale of Common Stock for $12M

Clearside Biomedical (NASDAQ: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced that it has closed the sale of 4,209,050 shares of common stock. The shares were priced at $2.851 per share, with the sale resulting in approximately $12 million. In the announcement, Clearside noted that the sale took…

Thursday Jan 28, 2021 - 1:02 pm

InvestorNewsBreaks – Brain Scientific Inc. (BRSF) Featured in BioWorld MedTech Article

Brain Scientific (OTCQB: BRSF), a neurology focused device and software company, was featured in a recent BioWorld MedTech article titled, “Brain Scientific begins development of E-Tattoo device for continuous brain monitoring.” The piece covers Brain Scientific’s efforts to combine a miniaturized electroencephalogram (“EEG”) with subcutaneous graphene electrodes to produce a minimally invasive brain monitoring device that could provide continuous data on patients with neurological conditions.…

Thursday Jan 28, 2021 - 12:10 pm

InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Enters Strategic Contract with Large Pharmaceutical Company

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced a contract between its wholly owned subsidiary, Soluble Biotech Inc., with a large pharmaceutical company. According to the update, the work will involve using Soluble Biotech’s proprietary protein formulation technology to improve the solubility and stability of a protein therapeutic destined for future clinical…

Thursday Jan 28, 2021 - 10:54 am

InvestorNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces Drug Formulation Strategy, 2021 Milestones

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) today announced its drug formulation and delivery business strategy and milestones for 2021. According to the update, XPhyto, as a bioscience accelerator at the leading-edge of the life science industry, targets growth through commercialization of its product pipeline and focused investment in impact driven innovation with the potential for meaningful value creation. Regarding XPhyto's drug formulation business,…

Thursday Jan 28, 2021 - 10:41 am

InvestorNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Completes Enrollment in First Cohort of MS1819 Study

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, announced that it has completed patient enrollment in the first cohort of its Phase 2b OPTION 2 extension study. The study is evaluating immediate-release capsules of MS1819 for the treatment of exocrine pancreatic insufficiency (“EPI”) in patients with cystic fibrosis (“CF”). In the announcement, the company noted that the Phase 2b OPTION…

Wednesday Jan 27, 2021 - 3:12 pm

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs Agreements to Acquire Leading Digital Musculoskeletal Company, Raise $70 Million Through Private Placement

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced that it has entered into a definitive agreement to acquire Upright Technologies Ltd., a digital musculoskeletal (“MSK”) company; the acquisition will be in the form of a stock transaction. The acquisition is designed to expand DarioHealth's multi-condition platform into the $213 billion musculoskeletal market and create one of the most comprehensive digital health…

Wednesday Jan 27, 2021 - 1:32 pm

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) CEO to Present at Upcoming Virtual Investor Conference Small and Microcap Showcase

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, this morning announced that the company’s president and CEO Rodney Varner will present at the Virtual Investor Conference Small and Microcap Showcase at 11 AM ET on February 4, 2021. Varner will be providing a virtual company overview, including a synopsis of its diabetes gene therapy and…

Wednesday Jan 27, 2021 - 12:18 pm

InvestorNewsBreaks – Predictive Oncology (NASDAQ: POAI) Closes Registered Direct Offering for $4.1 Million

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that it has closed of its previously announced registered direct offering. The offering comprised 3,414,970 shares of POAI’s common stock, offered at a purchase price of $1.20 per share, which was priced at-the-market under Nasdaq rules. The announcement noted that gross proceeds from this offering for…

Tuesday Jan 26, 2021 - 11:37 am

InvestorNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Addition of Two Clinical Trial Sites for MS1819 Phase 2b OPTION 2 Extension Study

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, has added two clinical trial sites for the extension arm of its MS1819 Phase 2b OPTION 2 study. The study is investigating immediate-release capsules of MS1819 for the treatment of exocrine pancreatic insufficiency (“EPI”) in patients with cystic fibrosis (“CF”). The additional sites were added in Poland; Europe was selected to reduce…

InvestorNewsBreaks

NewsBreak Category: Biotechnology

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions